Potential of ex vivo organotypic slice cultures in neuro-oncology
Neuro-Oncology · 10.02.2025 · 27 (2) · 338-351
DOI: 10.1093/neuonc/noae195 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuro-Oncology, online erschienen am 06.11.2024. Verfasst von Ariane Steindl und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Brain Neoplasms, Brain, Tissue Culture Techniques. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Over recent decades, in vitro and in vivo models have significantly advanced brain cancer research; however, each presents distinct challenges for accurately mimicking in situ conditions. In response, organotypic slice cultures have emerged as a promising model recapitulating precisely specific in vivo phenotypes through an ex vivo approach. Ex vivo organotypic brain slice models can integrate biological relevance and patient-specific variability early in drug discovery, thereby aiming for more precise treatment stratification. However, the challenges of obtaining representative fresh brain tissue, ensuring reproducibility, and maintaining essential central nervous system (CNS)-specific conditions reflecting the in situ situation over time have limited the direct application of ex vivo organotypic slice cultures in robust clinical trials. In this review, we explore the benefits and possible limitations of ex vivo organotypic brain slice cultures in neuro-oncological research. Additionally, we share insights from clinical experts in neuro-oncology on how to overcome these current limitations and improve the practical application of organotypic brain slice cultures beyond academic research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
- Brain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
ORCID-Profile: Manuel Valiente
Zitieren
APA
Steindl, A., & Valiente, M. (2025). Potential of ex vivo organotypic slice cultures in neuro-oncology. Neuro-Oncology, 27(2), 338-351. https://doi.org/10.1093/neuonc/noae195
Vancouver
Steindl A, Valiente M. Potential of ex vivo organotypic slice cultures in neuro-oncology. Neuro-Oncology. 2025;27(2):338-351. doi:10.1093/neuonc/noae195
BibTeX
@article{Steindl2025,
author = {Steindl, Ariane and Valiente, Manuel},
title = {Potential of ex vivo organotypic slice cultures in neuro-oncology},
journal = {Neuro-Oncology},
year = {2025},
volume = {27},
number = {2},
pages = {338--351},
doi = {10.1093/neuonc/noae195}
}
EUVIMED